Hori T, Uchiyama T, Tsudo M, Umadome H, Ohno H, Fukuhara S, Kita K, Uchino H
First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Blood. 1987 Oct;70(4):1069-72.
We established an interleukin 2 (IL-2)-dependent human T cell line, Kit 225, from a patient with T cell chronic lymphocytic leukemia (T-CLL) with OKT3+, -T4+, -T8- phenotype. Southern blot analysis showed that Kit 225 is not infected with human T cell leukemia/lymphoma virus (HTLV) type I or II, and is probably derived from the major clone in the fresh leukemic cells. Kit 225 cells express a large amount of IL 2 receptors constitutively and their growth is absolutely dependent on IL 2. No other stimuli, such as lectins or antigens, are required for maintaining the responsiveness to IL 2. As abnormal IL 2 receptor expression was also seen originally in the fresh leukemic cells, the establishment of this cell line with IL 2 suggests that IL 2-mediated T cell proliferation is involved in the leukemogenesis of some cases of HTLV-negative T-CLL.
我们从一名患有T细胞慢性淋巴细胞白血病(T-CLL)、具有OKT3 +、-T4 +、-T8 - 表型的患者中建立了一种白细胞介素2(IL-2)依赖的人T细胞系Kit 225。Southern印迹分析表明,Kit 225未感染I型或II型人T细胞白血病/淋巴瘤病毒(HTLV),可能源自新鲜白血病细胞中的主要克隆。Kit 225细胞组成性表达大量IL-2受体,其生长绝对依赖于IL-2。维持对IL-2的反应性不需要其他刺激,如凝集素或抗原。由于最初在新鲜白血病细胞中也观察到异常的IL-2受体表达,用IL-2建立该细胞系表明IL-2介导的T细胞增殖参与了某些HTLV阴性T-CLL病例的白血病发生。